Building a Better Future: Bristol Myers Squibb 2023 ESG Report
NORTHAMPTON, MA / ACCESSWIRE / April 11, 2024 / Bristol Myers Squibb Company:At Bristol Myers Squibb, our vision is to...
NORTHAMPTON, MA / ACCESSWIRE / April 11, 2024 / Bristol Myers Squibb Company:At Bristol Myers Squibb, our vision is to...
TAMPA, Fla.--(BUSINESS WIRE)--Smart Meter, the number one supplier of Cellular Remote Patient Monitoring (RPM)™, has confirmed that 71 out of...
Company to Showcase NextGen® Ambient Assist for Behavioral Health April 15-17 at NatCon 2024REMOTE-FIRST COMPANY/ST. LOUIS--(BUSINESS WIRE)--#NextGenHealthcare--As the healthtech industry...
Shaping the Future of Aesthetic Treatments with Advanced Medical TechnologyCLEARWATER, Fla.--(BUSINESS WIRE)--Apyx® Medical Corporation (NASDAQ:APYX) (the “Apyx Medical”; “Company”), the...
Toronto, Ontario--(Newsfile Corp. - April 11, 2024) - VitalHub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce...
London, United Kingdom--(Newsfile Corp. - April 11, 2024) - On April 1, 2024, Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the...
HENNINGSDORF, GERMANY / ACCESSWIRE / April 11, 2024 / Lindis Blood Care, a company aiming to set a new standard...
LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC),...
SEATTLE, WA / ACCESSWIRE / April 11, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
$59 million financing includes participation from new Icelandic institutional and existing investors; Extends cash runway until 2H 2026 The Central...
STUDIO CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and Black Swan Research Initiative® (BSRI)...
BEND, Ore., April 11, 2024 (GLOBE NEWSWIRE) -- 10 Barrel Brewing Co. (“10 Barrel”), an award-winning pioneer in the craft...
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical...
DENVER, April 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
State Health Benefit Plan members to engage in four-month steps challenge to reward two Georgia public schools with refurbished basketball...
TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
The Company’s neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer’s Phase 2 trial and anticipation of...
Successful completion of TVGN 489’s proof-of-concept clinical trial suggested the ability to target and eliminate a virus in high-risk population...
Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and...